Breaking News
|
GLOBAL-SWEDEN
|
Breaking News
|
GLOBAL-SWEDEN
|

A new study has uncovered promising therapeutic strategies against one of the deadliest forms of prostate cancer.
McGill University researchers at the Rosalind and Morris Goodman Cancer Institute (GCI) identified a mechanism driving neuroendocrine…

Public interest in drugs known as glucagon-like peptide-1 receptor agonists, also called GLP-1 RAs, has surged in recent years, with popular types like semaglutide (sold under brand names like Ozempic and Wegovy) becoming known…

Available data suggest that more than half of people with HIV get diagnosed at a late stage of infection, and that late diagnosis is more common among some migrant populations compared to non-migrants, resulting in poorer health outcomes and…
IRVINE, Calif., Nov. 20, 2025 (GLOBE NEWSWIRE) — InWith Corporation, a pioneer in smart vision technology, today announced an ambitious initiative to provide free prescription glasses and contact lenses to millions of people worldwide…

WALTHAM, Mass., Nov. 20, 2025 /PRNewswire/ — Mercy BioAnalytics, Inc., a pioneer in blood-based detection of early-stage cancer, today announced data from a groundbreaking study…

Amid unprecedented cuts to HIV/AIDS response globally, and to…


Reconstructing periocular and eyelid defects is a complex and multifaceted challenge that requires a careful balance between functional restoration and aesthetic outcomes. The periocular region is not only critical for protecting the ocular…

Researchers Albert Quintana and Salvador Ventura lead the two UAB research projects that were awarded funding in the 8th Call for Health Research from the “la Caixa” Foundation. The projects propose innovative approaches that could…